Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 INTRODUCTION OF GLOBAL METAGENOMIC SEQUENCING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL METAGENOMIC SEQUENCING MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL METAGENOMIC SEQUENCING MARKET, BY WORKFLOW
5.1 Overview
5.2 Sample Preparation
5.3 Sequencing
5.4 Data Processing and Analysis
6 GLOBAL METAGENOMIC SEQUENCING MARKET, BY PRODUCTS AND SERVICES
6.1 Overview
6.2 Instruments
6.3 Reagents and Consumables
6.4 Analysis and Data Interpretation Solutions
6.5 Metagenomic Sequencing Services
7 GLOBAL METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY
7.1 Overview
7.2 Shotgun Metagenomic Sequencing
7.3 16s Rrna Sequencing
7.4 Whole-Genome Sequencing and De Novo Assembly
7.5 Metatranscriptomics
8 GLOBAL METAGENOMIC SEQUENCINGMARKET, BY APPLICATION
8.1 Overview
8.2 Ecological and Environmental Metagenomics
8.3 Clinical Diagnostic Metagenomics
8.4 Drug Discovery Metagenomics
8.5 Soil Microbiome
8.6 Industrial Applications
8.7 Others
9 GLOBAL METAGENOMIC SEQUENCINGMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World
10 GLOBAL METAGENOMIC SEQUENCING MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Illumina
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Thermo Fisher Scientific
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Pacific Biosciences of California
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Qiagen
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 BGI
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Perkinelmer
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Oxford Nanopore Technologies
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Eurofins Genomics
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Gatc Biotech.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Macrogen
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
12 Appendix
12.1 Related Reports
Request Sample 
Request Discount 
Inquire Before Buy
